Publications by authors named "Anne Lewin"

Claim this Profile
S
Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance.
Andrew J Kavran, Yulong Bai, Brian Rabe, Anna Kreshock, Andrew Fisher, Anne Lewin

Front Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of spatial transcriptomics for oncology discovery.
Anna Lyubetskaya, Brian Rabe, Andrew Fisher, Anne Lewin, Isaac Neuhaus

Cell Rep Methods· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression.
Hong Shen, Tongtong Liu, Bridget L Morse, Yue Zhao, Yueping Zhang, Anne C Lewin

Drug Metab Dispos· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor and antiangiogenic activities of BMS-690514, an inhibitor of human EGF and VEGF receptor kinase families.
Tai W Wong, Francis Y Lee, Stuart Emanuel, Craig Fairchild, Joseph Fargnoli, Anne Lewin

Clin Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antiangiogenic activity in xenograft models of brivanib, a dual inhibitor of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinases.
Rajeev S Bhide, Louis J Lombardo, John T Hunt, Zhen-Wei Cai, Joel C Barrish, Anne C Lewin

Mol Cancer Ther· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic antitumor activity of ixabepilone (BMS-247550) plus bevacizumab in multiple in vivo tumor models.
Francis Y F Lee, Kelly L Covello, Stephen Castaneda, Donald R Hawken, David Kan, Anne Lewin

Clin Cancer Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist.
Mark Ayers, Joseph Fargnoli, Anne Lewin, Qiuyan Wu, J Suso Platero

Cancer Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis